AI Article Synopsis

  • The study explored the connection between maternal serum levels of pregnancy-specific beta-1-glycoprotein 1 (PSG1) and the onset of preeclampsia, comparing those levels in preeclamptic pregnancies versus healthy ones.
  • PSG1 levels were significantly lower in women with preeclampsia (11.60 ng/mL) compared to healthy controls (17.58 ng/mL), indicating a possible association between low PSG1 levels and preeclampsia risk.
  • The findings suggest that decreased PSG1 concentrations may signal placental dysfunction, highlighting its potential as a biomarker for detecting preeclampsia, with an optimal cut-off value set at ≤ 11.80 ng/mL.

Article Abstract

The aim of this study was to investigate the relationship between the maternal serum levels of pregnancy-specific beta-1-glycoprotein 1 (PSG1) and preeclampsia, and to compare levels of PSG1 in pregnancies with preeclampsia and uneventful pregnancies. A case-control study was conducted in a research and training hospital. A total of 40 women with preeclampsia and 42 healthy pregnant women who were gestational age-matched were included. Serum PSG1 levels were measured using enzyme-linked immunosorbent assay. The maternal serum PSG1 levels were significantly lower in patients with preeclampsia compared with controls (11.60 ± 8.08 vs. 17.58 ± 9.72 ng/mL,  = .003). Circulating PSG1 levels were negatively correlated with age in the preeclampsia and control groups ( = -0.322,  = .043), ( = -0.430,  = .005). PSG1 levels, age, blood urea nitrogen levels and birth weight were significantly associated with high odds of having preeclampsia. Receiver operating characteristic (ROC) curve analysis confirmed that the area under ROC curve was 0.707 (95% CI: [0.595-0.819],  < .001) for PSG1. The optimal cut-off value of PSG1 for detecting preeclampsia was ≤ 11.80 ng/mL. There may be a decrease in PSG1 production in preeclampsia-complicated pregnancies where there are pathologies related to placenta formation. A decline in PSG1 concentrations may reflect placental dysfunction.Impact Statement Previous studies have reported abnormal pregnancy-specific glycoprotein (PSG) levels in complicated pregnancies and demonstrated their importance in maintaining a healthy pregnancy. Human PSG homologues have been identified in species with haemochorial placentation such as non-human primates, rats and mice, where foetal cells are in direct contact with the maternal circulation. There are studies in which there is no clear relationship between PSGs and preeclampsia. We have demonstrated that circulating PSG1 levels were significantly lower in women with preeclampsia than in healthy pregnant women. There may be a decrease in PSG1 production in preeclampsia-complicated pregnancies where there are pathologies related to placenta formation and function. The results obtained from this current study could be used to clarify the relationship between PSG1 levels and preeclampsia. Evaluation of the role of circulating PSG1 levels in preeclampsia would be helpful in order to design further studies to determine the feasibility of using PSG1 as a serum marker to predict the risk of developing preeclampsia. The screening performance of PSG1 for preeclampsia is not yet clinically relevant, but may become so when evaluated together with other placental proteins. This will give a lead to further researches which could focus on the early detection of preeclampsia with the combination of several serum markers.

Download full-text PDF

Source
http://dx.doi.org/10.1080/01443615.2019.1679734DOI Listing

Publication Analysis

Top Keywords

psg1 levels
16
pregnancy-specific beta-1-glycoprotein
8
levels
8
pregnant women
8
women preeclampsia
8
maternal serum
8
serum psg1
8
roc curve
8
preeclampsia
7
psg1
6

Similar Publications

The mechanisms linking a history of major depressive disorder (MDD) to an increased risk of Alzheimer's disease and related dementia (ADRD) are not fully understood. Using the UK Biobank available proteomic and genomic data, we evaluated the biological mechanisms linking both conditions. In participants with a history of MDD at baseline (n=3,615), we found that plasma levels of NfL, GFAP, PSG1 were associated with higher risk (HR=1.

View Article and Find Full Text PDF

The impaired invasion ability of trophoblast cells is related to the occurrence of preeclampsia (PE). We previously found that pregnancy-specific beta-1-glycoprotein 1 (PSG1) levels were decreased in the serum of individuals with early-onset preeclampsia (EOPE). This study investigated the effect of PSG1 on Orai1-mediated store-operated calcium entry (SOCE) and the Akt signaling pathway in human trophoblast cell migration.

View Article and Find Full Text PDF

Chronic hypertension is one of the major risk factors for preeclampsia. Pregnancy-specific beta-1-glycoprotein (PSG-1) is a protein that plays a critical role in fetomaternal immune modulation and has been shown to be closely associated with pregnancy adverse events such as preeclampsia. It is also known that PSG-1 and its source placenta are associated with many molecular pathways associated with blood pressure regulation.

View Article and Find Full Text PDF
Article Synopsis
  • - The SARS-CoV-2 pandemic posed significant risks to pregnant women and newborns, highlighting the importance of the maternal immune system in managing infections while supporting fetal growth.
  • - Galectins, proteins that play a role in immune regulation, are essential for successful pregnancies, with recent studies indicating their involvement in the immune response to SARS-CoV-2 infection.
  • - In the study, maternal levels of galectin-1 increased with SARS-CoV-2 infection, while pregnancy-specific glycoprotein 1 levels rose only during infection; the research reveals a complex relationship between these proteins and pregnancy health during the pandemic.
View Article and Find Full Text PDF

Pregnancy-specific beta-1-glycoprotein 1-enriched exosomes are involved in the regulation of vascular endothelial cell function during pregnancy.

Placenta

August 2023

Clinical and Translational Research Center, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address:

Introduction: Pregnancy is a dynamic time period associated with significant physiological changes in the cardiovascular system. It is well known that during pregnancy, the placenta secretes a variety of molecular signals, including exosomes, into the maternal circulation to adapt to increased blood volume and maintain blood pressure at normotensive levels.

Methods: In the present study, we compared the effects of exosomes derived from the peripheral blood serum of nonpregnant women (NP-Exo) and pregnant women with uncomplicated pregnancy (P-Exo) on endothelial cell function.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!